Search alternatives:
_ decrease » _ increase (Expand Search)
Showing 1 - 17 results of 17 for search '(( 50 c decrease ) OR ((( 50 i decrease ) OR ((( _ _ decrease ) OR ( 5 mg decrease ))))))~', query time: 0.11s Refine Results
  1. 1

    One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes by Goran Petrovski (129836)

    Published 2022
    “…HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). …”
  2. 2

    10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes by Goran Petrovski (129836)

    Published 2020
    “…The participants used the sensor for a median of 92% of the time and spent a median of 89% in Auto Mode. The mean HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at the end of the study (p = 0.017). …”
  3. 3
  4. 4
  5. 5

    β-2-himachalen-6-ol protects against skin cancer development in vitro and in vivo by Daaboul, Hamid E.

    Published 2017
    “…This study investigated the anticancer activity of HC against invasive epidermal squamous cell carcinoma cells and evaluated its effect in a DMBA/TPA skin carcinogenesis Balb/c murine model. Methods HaCaT-ras II-4 epidermal squamous cells were treated with HC (1, 5, 10, 25 and 50 μg/ml), and cell viability was evaluated with WST 1 assay kit. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Wild carrot pentane-based fractions suppress proliferation of human HaCaT keratinocytes and protect against chemically-induced skin cancer by Shebaby, Wassim N.

    Published 2017
    “…Treatment of HaCaT-ras A5 and HaCaT-ras II4 cells with F2 fraction resulted in the accumulation of cells in the sub-G1 apoptotic phase and decreased the population of cells in the S and G2/M phases. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  13. 13
  14. 14

    Impact of composition and salinity on swelling and gel strength of poly (acrylamide-co-acrylic acid) preformed particle gel by Ahmed Ben Ali (17792594)

    Published 2023
    “…The swelling ratios of the PPGs in brine 1 at 50 °C were between 12 and 32 g/g, having strengths in the range of 566–5508 Pa, depending on the crosslinker ratio. …”
  15. 15

    Biodegradable polysaccharide grafted polyacrylamide inhibitor for corrosion in CO<sub>2</sub>- saturated saline solution by Rem Jalab (11715205)

    Published 2023
    “…Results demonstrated the promising performance of AGGPAM in improving steel resistivity, achieving 85% efficiency at 500 mg L<sup>−1</sup> and reducing the corrosion rate from 33 to 4.9 mils per year at 25 °C. …”
  16. 16

    Application of Fe<sub>3</sub>O<sub>4</sub> magnetite nanoparticles grafted in silica (SiO<sub>2</sub>) for oil recovery from oil in water emulsions by Wamda Faisal Elmobarak (17058024)

    Published 2021
    “…An excellent %<sub>hdem</sub> 90% was achieved C<sub>oil</sub> in the range 50 e2000 mg/L. Using an MD<sub>dose</sub> as low as 10 mg/L attained a %<sub>hdem</sub> in the range of 93% - 4.3% for O/W mixtures with C<sub>oil</sub> < 2000 mg/L, which slightly decreased to ~90% for higher concentrations. …”
  17. 17

    Small molecule inhibition of stat3 enhances survival in mice with intracerebral melanoma by Abou-Ghazal, Mohamed

    Published 2008
    “…In the study described here, we tested that in mouse models WP1066, a novel STAT3 pathway blockade agent, has marked in vitro and in vivo activity, even with metastasis to the brain, a site typically refractory to therapies. WP1066 achieved an IC50 of 1.6 μM, 2.3 μM, and 1.5 μM against the human melanoma cell line A375, murine melanoma cell line B16, and B16EGFRvIII, respectively. …”
    Get full text
    Get full text
    Get full text
    conferenceObject